NR 566 Midterm NR566 MIDTERM EXAM
REVIEW /LATEST ADVANCED
PHARMACOLOGY FOR CARE OF
FAMILY|AGRADE
Which non- o
amphetamines are FDA approved for weight loss that have lower abuse risk? ...
o o o o o o o o o o o o
.......ANSWER.......Phentermine and Diethylpropion o o
How does Phentermine and Diethylpropion promote weight loss? ..........ANS
o o o o o o o o
WER.......-Promote weight loss by decreasing appetite
o o o o o
-
They are central nervous system (CNS) stimulants that suppress appetite by in
o o o o o o o o o o o
creasing the availability of norepinephrine at receptors in the brain
o o o o o o o o o
What is the maximum recommended duration of use for non-
o o o o o o o o o
amphetamines? ..........ANSWER.......3 months or less
o o o o
What drug schedule are Phentermine and Diethylpropion under? ..........ANS
o o o o o o o o
WER.......Schedule IV o
,2|Page
What labs should be monitored with Phentermine and Diethylpropion? What
o o o o o o o o o o
condition should we screen for? ..........ANSWER.......-
o o o o o
baseline CMP (watch electrolytes and creatinine)
o o o o o
-screen for depression o o
Phentermine adverse effects ..........ANSWER.......-increase HR and BP
o o o o o o
-dry mouth and constipation
o o o
What is role of topiramate in weight loss? ..........ANSWER.......Increases satiety
o o o o o o o o o
What are some Phentermine/topiramate contraindications for use? ..........AN
o o o o o o o
SWER.......not approved in children and contraindicated with severe hepatic i
o o o o o o o o o
mpairment
How should we educate patient to take Phentermine/topiramate to avoid inso
o o o o o o o o o o
mnia? ..........ANSWER.......given before 1600
o o o
What are some high-
o o o
risk patient conditions that we should use Phentermine/topiramate with cauti
o o o o o o o o o
on? ..........ANSWER.......hx drug abuse, glaucoma, pregnant, HTN, hyperthyroi
o o o o o o o
dism
,3|Page
Phentermine/topiramate adverse effects ..........ANSWER.......insomnia, nervo o o o o
usness, anxiety, depression, blurred vision
o o o o
Which of the following would be a contraindication to prescribing phentermi
o o o o o o o o o o
ne/topiramate? Select all that apply. ..........ANSWER.......A) Glaucoma
o o o o o o
B) Hypothyroidism
o
C) Hypertension
o
D) Hyperthyroidism
o
E) Vitamin D Deficiency
o o o
F) A, B, E
o o o
ANSWER: A,C,D o
Orlistat is a lipase inhibitor that acts on the _________ and reduces absorption
o o o o o o o o o o o o
o of fat by 30%. ..........ANSWER.......GI tract
o o o o o
Take multivitamin ___hours before/after to supplement fat-
o o o o o o
soluble vitamins that may not be absorbed well when taking Orlistat. ..........A
o o o o o o o o o o o
NSWER.......2
, 4|Page
Orlistat is OTC as 60 mg TID with meals. Not approved in children <____. .......
o o o o o o o o o o o o o o
...ANSWER.......12
Orlistat results in the least amount of weight loss of all. How much? ..........ANS
o o o o o o o o o o o o o
WER.......2-3% body weight (7 lbs in year)
o o o o o o
Orlistat adverse effects ..........ANSWER.......Fecal incontinence, oily rectal leak
o o o o o o o
age, flatus, abdominal cramps. liver damage (light-
o o o o o o
colored stools, dark urine, fatigue, jaundice, anorexia)
o o o o o o
When is Orlistat contraindicated? ..........ANSWER.......In those with malabsor
o o o o o o o
ption syndrome or cholestasis
o o o
What vitamin deficiency are we concerned about when taking Orlistat...especi
o o o o o o o o o
ally if the patient is on coumadin? ..........ANSWER.......Monitor Coumadin as V
o o o o o o o o o o
itamin K deficiency may occur and intensify effect of Coumadin.
o o o o o o o o o
A patient with a BMI of 27 would be considered: ..........ANSWER.......overweig
o o o o o o o o o o
ht